🔬 Current Disease Focus:
Task Progress: 0%
👥 Active Problem Solvers
0
🌍 Experts collaborating globally
⚡ Current Task Assignment
🧬 Genetic Analysis
🔄 Matching experts to specific tasks
📊 Resource Allocation by Research Phase:
📚 Data Analysis
🧪 Experimental Design
🔬 Clinical Trials
💊 Treatment Development
To establish the bioequivalence between Acarbose / Metformin FDC (50mg / 50...
Status
Completed
Location
Multiple Locations
Start Date
2012-09
Trial ID
NCT01728740
Treatments Being Tested
The objective of this study is to assess the efficacy and safety under prac...
Status
Completed
Location
Multiple Locations
Start Date
2010-11
Trial ID
NCT01685502
Treatments Being Tested
The purpose of this study is to evaluate the efficacy and safety of acarbos...
Status
Completed
Location
Multiple Locations
Start Date
2009-11
Trial ID
NCT00970528
Treatments Being Tested
It has been recently suggested, that not the diet by itself, but also patie...
Status
Completed
Location
Multiple Locations
Start Date
2008-05
Trial ID
NCT01333774
Treatments Being Tested
To establish the bioequivalence between Glucobay ODT (Orally Disintegrating...
Status
Completed
Location
Multiple Locations
Start Date
2012-03
Trial ID
NCT01554631
Treatments Being Tested
To evaluate the effectiveness of Glucobay when combined with a basal insuli...
Status
Completed
Location
Multiple Locations
Start Date
2010-09
Trial ID
NCT01248481
Treatments Being Tested
The use of acarbose in impaired glucose tolerance (IGT) and type 2 diabetic...
Status
Completed
Location
Multiple Locations
Start Date
2007-05
Trial ID
NCT01167231
Treatments Being Tested
In this prospective, non interventional, observational Post Marketing Surve...
Status
Completed
Location
Multiple Locations
Start Date
2008-04
Trial ID
NCT01613105
Treatments Being Tested
The purpose of the study is to determine if the administration of small dos...
Status
Completed
Location
Multiple Locations
Start Date
2000-08
Trial ID
NCT01010100
Treatments Being Tested
To establish the bioequivalence between Glucobay ODT (Orally Disintegrating...
Status
Completed
Location
Multiple Locations
Start Date
2011-06
Trial ID
NCT01388153